Sunday, 20 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14437
Articles
Company
Drug
Abbisko Therapeutics’ FGFR4 Inhibitor Irpagratinib Granted Breakthrough Therapy Designation for HCC
May 26, 2025
Company
Deals
Elpiscience Files for Hong Kong IPO Focusing on Immunotherapy Pipeline
May 26, 2025
Company
Deals
Medilink Therapeutics Collaborates with Wuhan Union Hospital on Clinical Trials
May 26, 2025
Company
Drug
Duality Biologics Receives FDA IND Approval for EGFR/HER3 ADC AVZO-1418
May 26, 2025
Company
Drug
Zhejiang Huahai Gains MEDSAFE and HDEC Approval for HB0043 Phase I Trial
May 26, 2025
Company
Drug
Bayer’s Eylea 8 mg Close to EU Approval for Longer Treatment Intervals
May 26, 2025
Company
Deals
Sichuan Kelun-Biotech Finalizes Licensing Deal for TSLP Monoclonal Antibody
May 26, 2025
Company
Drug
Roche’s Itovebi Recommended for EU Approval in PIK3CA-Mutated Breast Cancer
May 26, 2025
Company
Medical Device
Jenscare Announces Positive 30-Day Results for LuX-Valve Plus in TRINITY Study
May 26, 2025
Company
Deals
Roche Partners with Broad Clinical Labs to Advance SBX Sequencing Technology
May 26, 2025
Company
Drug
Grand Pharma’s GPN01768 Approved in Macau for Demodectic Blepharitis
May 26, 2025
Company
Medical Device
Medtronic’s Prevail DCB Gains CE Mark for Expanded Coronary Disease Indications
May 26, 2025
1
2
…
353
354
355
356
357
…
1,203
1,204
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?